Childhood Cancers Subject of New Law

Publication
Article
OncologyONCOLOGY Vol 14 No 12
Volume 14
Issue 12

At the end of its session, Congress passed a children’s health bill (H.R. 4365) that established a variety of new health programs. One section of the bill authorizes the CDC to study environmental and other risk factors for childhood cancers,

At the end of its session, Congress passed a children’shealth bill (H.R. 4365) that established a variety of new health programs. Onesection of the bill authorizes the CDC to study environmental and other riskfactors for childhood cancers, including skeletal malignancies, leukemias,malignant tumors of the central nervous system, lymphomas, soft-tissue sarcomas,and other malignant neoplasms. In addition to studying those conditions, the CDCwas told to fund projects to improve outcomes among children with those cancersand resulting secondary conditions, such as loss of limbs. The CDC already has aprogram to help states set up cancer registries. The states themselves decidewhat the registries will focus on, and some of them are very narrowly gauged.Thirty-nine states have registries. The CDC gave away $24 million in fiscal year2000 to these state registries. Very few of the states do much with regard tochildhood cancers, and the CDC will ostensibly try to change this. Thejust-passed bill instructs the CDC to set up a national reporting system thatwill involve oncologists, who will have to provide diagnosis and epidemiolgicdata.

Recent Videos
Shwetal Mehta, PhD, describes efforts regarding the development of protein degraders and antibody-drug conjugates in the neuro-oncology field.
Liquid biopsy tests may help determine the extent of activity among patients who receive a novel fourth-generation EGFR inhibitor for brain cancer.
Shwetal Mehta, PhD, highlights novel brain cancer drug development procedures in the clinical lab and pre-clinical arms of the Ivy Brain Tumor Center.
Raymond B. Mailhot, MD, MPH, discussed how radiation therapy can impact education and survivorship for pediatric survivors of brain tumors.
Significant results from a retrospective analysis of brain tumor survivor academic performance after radiotherapy emerged despite small sampling size.
Raymond B. Mailhot, MD, MPH, discussed methods for comparing academic performances of patients following radiation therapy with healthy control groups.
The act of asking for help is critical to finding mentors who can help one advance in the brain cancer field, according to Yoshie Umemura, MD.
Through multidisciplinary collaboration, Yoshie Umemura, MD, and colleagues were able to organize the Gliofocus trial in brain cancer relatively fast.
Related Content